Testing....
Cord blood stem cells have a unique and powerful ability to regenerate blood cells that have been damaged by disease or medical conditions. Through stem cell transplants, cord blood stem cells can save lives and improve treatment outcomes. Cord blood can also play a critical role in preventing graft-versus-host-disease, which is a potentially fatal condition that occurs when a patient’s body rejects transplanted stem cells.
Parents are always searching for ways to keep their children and family safe. When a debilitating disease or medical condition arises, you want to know that there are accessible, effective treatments immediately available to you and your loved ones. The statistics may surprise you:
Every 4 minutes, one person is diagnosed with a blood cancer
Every 10 minutes, someone dies from a blood cancer
80 diseases are FDA approved for routine treatment with cord blood stem cells
1 in 3 people may benefit from stem cell regenerative medicine therapy
There have been 85,000 cord blood transplants worldwide, and there more than 5,200 clinical trials exploring the use of cord blood stem cells for new therapies.
Banking your baby’s cord blood provides you with life-giving stem cells and offers a lifetime of comfort knowing that you can access your baby’s preserved stem cells at any time.
Blood Disorders
Acute Myelofibrosis
Agnogenic Myeloid Metaplasia (Myelofibrosis)
Amyloidosis
Aplastic Anemia (Severe)
Beta Thalassemia Major
Blackfan-Diamond Anemia
Congenital Amegakaryocytic Thrombocytopenia (CAT)
Congenital Cytopenia
Congenital Dyserythropoietic Anemia
Dyskeratosis Congenita
Essential Thrombocythemia
Fanconi Anemia
Glanzmann’s Thrombasthenia
Myelodysplastic Syndrome
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Polycythemia Vera
Pure Red Cell Aplasia
Refractory Anemia with Excess Blasts (RAEB)
Refractory Anemia with Excess Blasts in Transition (RAEB-T)
Refractory Anemia with Ringed Sideroblasts (RARS)
Shwachman-Diamond Syndrome
Sickle Cell Disease
Cancers
Acute Biphenotypic Leukemia
Acute Lymphocytic Leukemia (ALL)
Acute Myelogenous Leukemia (AML)
Acute Undifferentiated Leukemia
Adult T Cell Leukemia/Lymphoma
Chronic Active Epstein Barr
Chronic Lymphocytic Leukemia (CLL)
Chronic Myelogenous Leukemia (CML)
Chronic Myelomonocytic Leukemia (CMML)
Ewing Sarcoma
Hodgkin’s Lymphoma
Juvenile Chronic Myelogenous Leukemia (JCML)
Juvenile Myelomonocytic Leukemia (JMML)
Myeloid/Natural Killer (NK) Cell PrecursorAcute Leukemia
Non-Hodgkin’s Lymphoma
Prolymphocytic Leukemia
Plasma Cell Leukemia
Leukocyte Adhesion Deficiency
Multiple Myeloma
Neuroblastoma
Rhabdomyosarcoma
Thymoma (Thymic Carcinoma)
Waldenstrom’s Macroglobulinemia
Wilms Tumor
Immune Disorders
Adenosine Deaminase Deficiency (SCID)
Bare Lymphocyte Syndrome (SCID)
Chediak-Higashi Syndrome (SCID)
Chronic Granulomatous Disease
Congenital Neutropenia
DiGeorge Syndrome
Evans Syndrome
Fucosidosis
Hemophagocytic Lymphohistiocytosis (HLH)
Hemophagocytosis Langerhans’ Cell Histiocytosis (Histiocytosis X)
IKK Gamma Deficiency (NEMO Deficiency)
Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-linked (IPEX) Syndrome
Kostmann Syndrome (SCID)
Myelokathexis
Omenn Syndrome (SCID)
Phosphorylase Deficiency (SCID)
Purine Nucleoside (SCID)
Reticular Dysgenesis (SCID)
Severe Combined Immunodeficiency Diseases (SCID)
Thymic Dysplasia
Wiskott-Aldrich Syndrome
X-linked Agammaglobulinemia
X-Linked Hyper IgM Syndrome
X-Linked Lymphoproliferative Disorder
Metabolic Disorders
Congenital Erythropoietic Porphyria (Gunther Disease)
Gaucher Disease
Hunter Syndrome (MPS-II)
Hurler Syndrome (MPS-IH)
Krabbe Disease
Lesch-Nyhan Syndrome
Mannosidosis
Maroteaux-Lamy Syndrome (MPS-VI)
Metachromatic Leukodystrophy
Mucolipidosis II (I-cell Disease)
Neuronal Ceroid Lipofuscinosis (Batten Disease)
Niemann-Pick Disease
Sandhoff Disease
Sanfilippo Syndrome (MPS-III)
Scheie Syndrome (MPS-IS)
Sly Syndrome (MPS-VII)
Tay Sachs
Wolman Disease
X-Linked Adrenoleukodystrophy
Note: Some diseases may be known by other names. The use of umbilical cord blood stem cells to treat many diseases and conditions is typically considered standard therapy, while the treatment for other conditions may still be in a clinical trial phase. Currently, stem cells are being used in trials for the treatment of brain injuries, cerebral palsy, autism, diabetes, spinal cord injuries, heart disease, liver disease, and others. These conditions have not been included in this list.
